About HyperBranch Medical
HyperBranch Medical is a company based in Durham (United States) founded in 2003 was acquired by Stryker in October 2018. HyperBranch Medical has raised $18.69 million across 9 funding rounds from investors including Stryker, The Aurora Funds and H.I.G. Capital. HyperBranch Medical operates in a competitive market with competitors including Adhezion Biomedical, BRIJ Medical, BORAYER, Inno Therapy and Mussel Polymers, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of HyperBranch Medical
HyperBranch Medical has successfully raised a total of $18.69M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $2 million completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HyperBranch Medical
HyperBranch Medical has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, The Aurora Funds and H.I.G. Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Private equity capital is invested in small and mid-sized businesses.
|
Locked | Locked | Locked | |
|
3D-printed orthopedic products are manufactured for medical applications.
|
Locked | Locked | Locked |
Investor details for HyperBranch Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HyperBranch Medical
Investment portfolio details for HyperBranch Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HyperBranch Medical
Detailed financials for HyperBranch Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hyperbranch Medical Comparisons
Peer comparison for HyperBranch Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HyperBranch Medical
HyperBranch Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adhezion Biomedical, BRIJ Medical, BORAYER, Inno Therapy and Mussel Polymers, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cyanoacrylate based surgical, wound management, and infection prevention products
|
|
| Locked | Locked | Locked |
Medical devices for post-surgical and trauma incision care are provided.
|
|
| Locked | Locked | Locked |
Biomaterials for surgery and wound repair are developed.
|
|
| Locked | Locked | Locked |
Hemostatic polymers are produced for surgical and wound care applications.
|
|
| Locked | Locked | Locked |
Adhesive solutions are manufactured for diverse materials and applications.
|
Detailed competitors of HyperBranch Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hyperbranch Medical
Complete news archive for HyperBranch Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HyperBranch Medical
HyperBranch Medical was founded in 2003 and raised its 1st funding round 2 years after it was founded.
HyperBranch Medical is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
HyperBranch Medical is a funded company, having raised a total of $18.69M across 9 funding rounds to date.
HyperBranch Medical is focused on biosurgical devices based on its proprietary polymers and cross-linked hydrogels. Initial focus is on the surgical sealant market. Lead product is the Adherus AutoSpray Dural Sealant, used to provide closure during surgical procedures. Licensed its liquid ocular bandage technology to Becton Dickinson in 2009. Approved by FDA in Mar 2015 and received CE Mark in 2012.
HyperBranch Medical's top competitors include Adhezion Biomedical, BRIJ Medical and Inno Therapy.
HyperBranch Medical has 3 investors. Key investors include Stryker, The Aurora Funds, and H.I.G. Capital.